13May 2023
Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta‐analysis

Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta‐analysis

Midlife obesity and late-life weight loss increase the risk of developing dementia and Alzheimer's disease (AD). The role of gastrointestinal factors in this phenomenon is not yet fully understood. A systematic review and meta-analysis of 42 cross-sectional and 13 longitudinal studies were conducted to explore the associations between gastrointestinal factors (leptin, adiponectin, resistin, and ghrelin) and the prevalence of general dementia, AD, and mild cognitive impairment (MCI). Results indicate that patients with AD had lower blood leptin and higher resistin levels than cognitively normal individuals. Lower leptin and higher resistin were associated with greater cognitive impairment. Lower late-life leptin levels may also be linked to a higher prospective risk of dementia and AD. The study may contribute to identifying new blood markers of MCI and AD.

  • #endo-diabetology

Like

Save

Share